CorMedix (CRMD) Interest Coverage Ratio (2012 - 2025)
CorMedix (CRMD) reported Interest Coverage Ratio of 23.01 for Q4 2025, up 120.81% on a YoY basis from 10.42 in Q4 2024, and up 12449.41% sequentially from 0.18 in Q3 2025.
CorMedix (CRMD) Interest Coverage Ratio (2012 - 2025) Analysis & Trends
CorMedix (CRMD) has 14 years of Interest Coverage Ratio data on file, last reported at 23.01 in Q4 2025.
- For the quarter ending Q4 2025, Interest Coverage Ratio rose 120.81% year-over-year to 23.01; the trailing twelve-month figure through Dec 2025 stood at 59.82 (down 97.48% YoY), and the FY2025 full-year result was 1.32, up 239.66% from the prior year.
- Interest Coverage Ratio advanced to 23.01 in Q4 2025, from 0.18 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 37.97 in Q1 2025 to a low of 2389.99 in Q4 2023.
- A 5-year average of 364.97 and a median of 77.5 in 2024 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio slumped 111912.64% in 2022 and jumped 138.42% in 2025, its largest moves.
- Tracing CRMD's Interest Coverage Ratio over 5 years: stood at 1446.62 in 2021, then soared by 96.8% to 46.28 in 2022, then slumped by 5063.87% to 2389.99 in 2023, then soared by 95.37% to 110.58 in 2024, then surged by 120.81% to 23.01 in 2025.
- Business Quant data shows CRMD's Interest Coverage Ratio at 23.01 in Q4 2025, 0.18 in Q3 2025, and 8.19 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn | 23.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.01 |
| Sep 30, 2025 | 0.18 |
| Jun 30, 2025 | 8.19 |
| Mar 31, 2025 | 37.97 |
| Dec 31, 2024 | -110.58 |
| Sep 30, 2024 | -64.46 |
| Jun 30, 2024 | -90.54 |
| Mar 31, 2024 | -98.84 |
| Dec 31, 2023 | -2,389.99 |
| Sep 30, 2023 | -209.35 |
| Jun 30, 2023 | -236.09 |
| Mar 31, 2023 | -220.34 |
| Dec 31, 2022 | -46.28 |
| Sep 30, 2022 | -139.24 |
| Jun 30, 2022 | -2,298.59 |
| Mar 31, 2022 | -6.15 |
| Dec 31, 2021 | -1,446.62 |
| Sep 30, 2021 | -9.00 |
| Jun 30, 2021 | -2.05 |
| Mar 31, 2021 | -0.72 |